Yan Huang(黄岩)

中山大学附属肿瘤医院

Show Academic Trajectory

Ego Network

D-Core

Research Interests

Author Statistics

Experience

Education

Bio

专长：肺癌和鼻咽癌的化疗、靶向治疗、免疫治疗及新药临床研究

社会兼职：
中国抗癌协会肿瘤药物临床研究专业委员会委员
CSCO肿瘤支持与康复治疗专家委员会常务委员
广东省抗癌协会化疗专业委员会常务委员
广东省抗癌协会癌症康复与姑息治疗专业委员会常务委员
广东省临床医学学会精准医疗专业委员会副主任委员

Papers179 papers

Sort

By YearBy Citation

Evaluation of immune response to Bacillus subtilis spores expressing Clonorchis sinensis serpin3

Zhipeng Lin,Hengchang Sun, Yan Ma, Xinyi Zhou, Hongye Jiang, Xi Wang, Jiaman Song,Zeli Tang, Qing Bian, Zhen Zhang,Yan Huang,Xinbing Yu

Parasitology, pp.1-27, (2020)

WOSBibtex

Duration of FOLFOX Adjuvant Chemotherapy in High-Risk Stage II and Stage III Colon Cancer With Deficient Mismatch Repair

Huabin Hu, Zehua Wu, Chao Wang,Yan Huang,Jianwei Zhang,Yue Cai, Xiaoyu Xie, Jianxia Li, Cailu Shen, Weiwei Li,Jiayu Ling,Xuehu Xu

Frontiers in oncology, (2020): 579478

WOSBibtex

Efficacy and Tolerability of Erlotinib 100 mg/d vs. Gefitinib 250 mg/d in EGFR-Mutated Advanced Non-small Cell Lung Cancer (E100VG250): An Open-Label, Randomized, Phase 2 Study

Shen Zhao,Zhen Zhang,Wenfeng Fang,Yaxiong Zhang, Zhonghan Zhang,Shaodong Hong,Yuxiang Ma,Ting Zhou,Yunpeng Yang,Yan Huang,Hongyun Zhao,Li Zhang

Frontiers in oncology, (2020): 587849

WOSBibtex

CLINICAL CHARACTERISTICS AND TREATMENT RESPONSE IN JUVENILE GOUT PATIENTS: A SINGLE CENTER EXPERIENCE

S. Zheng, P. Y. Lee,Y. Huang,Q. Huang,S. Chen,T. W. Li

ANNALS OF THE RHEUMATIC DISEASES, no. SUPnan (2020): 1206-1206

Bibtex

COMORBIDITIES AND FACTORS INFLUENCING RECURRENT GOUT ATTACK IN PATIENTS WITH GOUT: A CROSS-SECTIONAL STUDY

Y. Jiang,Z. Liao,Y. Huang,J. Liang,Y. Xie,J. Wu,J. Gu

ANNALS OF THE RHEUMATIC DISEASES, no. SUPnan (2020): 1937-1937

Bibtex

Immunotherapy or other anti cancer treatments and risk of exacerbation and mortality in cancer patients with COVID 19: a systematic review and meta analysis

Bolin Wang,Yan Huang

OncoImmunology, (2020)

Bibtex

Oral delivery of Bacillus subtilis spores expressing Clonorchis sinensis paramyosin protects grass carp from cercaria infection

Hengchang Sun,Mei Shang,Zeli Tang, Hongye Jiang, Huimin Dong, Xinyi Zhou, Zhipeng Lin,Cunbin Shi, Pengli Ren, Lu Zhao,Mengchen Shi,Lina Zhou

Applied Microbiology and Biotechnology, no. 4 (2020): 1-14

WOSBibtex

mFOLFOXIRI with or without cetuximab as conversion therapy in patients with RAS/BRAF wild-type unresectable liver metastases colorectal cancer: The FOCULM study

Huabin Hu, Kun Wang,Wei Wang, Meng Qiu, Rongbo Lin, Haibo Zhang,GuangJian Liu, Yunle Wan,Liang Kang,Hui Wang,Zhiyang Zhou, Fangqian Li

Journal of Clinical Oncology, (2020): 99-99

Bibtex

Modified FOLFOXIRI With or Without Cetuximab as Conversion Therapy in Patients with RAS/BRAF Wild-Type Unresectable Liver Metastases Colorectal Cancer: The FOCULM Multicenter Phase II Trial

Huabin Hu,Kun Wang,Meijin Huang,Liang Kang,Wei Wang,Hui Wang,Meng Qiu, Rongbo Lin,Haibo Zhang,Ping Lan,Xiaojian Wu,Guangjian Liu

The oncologist, (2020)

WOSBibtex

Establishment and application of a predictive model for gefitinib-induced severe rash based on pharmacometabolomic profiling and polymorphisms of transporters in non-small cell lung cancer

Shaoxing Guan,Xi Chen,Shuang Xin, Shu Liu,Yunpeng Yang,Wenfeng Fang,Yan Huang,Hongyun Zhao,Xia Zhu,Wei Zhuang,Fei Wang,Wei Feng

Translational oncology, no. 1 (2020): 100951

WOSBibtex

Density and distribution of lymphocytes in pretherapeutic rectal cancer and response to neoadjuvant therapy

Sicong Lai, Xiaoying Lou,Xinjuan Fan, Weipeng Sun,Yanhong Deng,Jianping Wang,Yan Huang, Ruoxu Dou

Gastroenterology Report, (2020)

Bibtex

Prognostic value of serum high-density lipoprotein cholesterol elevation in nonsmall cell lung cancer patients receiving radical surgery

Fan Luo, Kang‐mei Zeng, Zhong‐han Zhang,Ting Zhou,Jian‐hua Zhan, Fei‐teng Lu,Yun‐peng Yang,Yan Huang,Li Zhang,Hong‐yun Zhao

Clinical and translational medicine, (2020)

Bibtex

In vivo and in vitro studies using Clonorchis sinensis adult-derived total protein (CsTP) on cellular function and inflammatory effect in mouse and cell model

Mei Shang,Hengchang Sun, Yinjuan Wu, Yu Gong,Zeli Tang, Fangang Meng, Lei He,Xinbing Yu,Yan Huang,Xuerong Li

Parasitology Research, no. 5 (2020): 1641-1652

WOSBibtex

Duration of FOLFOX adjuvant chemotherapy in high-risk stage II and stage III colon cancer with deficient DNA mismatch repair

Zehua Wu,Huabin Hu, Chao Wang,Yan Huang,Yanhong Deng

Journal of Clinical Oncology, (2020): 4075-4075

Bibtex

Prognostic and predictive value of DNA mismatch repair status in patients with locally advanced rectal cancer following neoadjuvant therapy

Huabin Hu, Chao Wang, Zehua Wu,Yan Huang,Jianwei Zhang,Yue Cai, Xiaoyu Xie,Jiayu Ling,Yanhong Deng

Journal of Clinical Oncology, (2020): 210-210

Bibtex

Fosaprepitant versus aprepitant in the prevention of chemotherapy-induced nausea and vomiting in patients receiving cisplatin-based chemotherapy: a multicenter, randomized, double-blind, double-simulated, positive-controlled phase III trial

Zhonghan Zhang,Yunpeng Yang, Ping Lu, Xiaoqin Li,Jianhua Chang, Rongsheng Zheng, Lei Zhou, Shaoshui Chen, Xiaopin Chen, Biyong Ren, Wei Gu, Xiaodong Jiang

ANNALS OF TRANSLATIONAL MEDICINE, no. 5.0 (2020): 234

WOSBibtex

[Pulmonary Nodules/Lung Cancer Comprehensive Management Mode: Design and Application]